Prothena | PRTA - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 5.88B 1.26B 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Exelixis USD 10.89B 857M 2026-03
Immunic USD 64M 23M 2025-12
Incyte USD 18.73B 660M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
MacroGenics USD 287M 103M 2026-07
Nektar Therapeutics USD 12.82B 11.96B 2026-07
Neurocrine Biosciences USD 13.25B 890M 2026-03
Prothena USD 526M 10M 2026-07
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03